News tagged with 'LYMErix'

Citing diminishing sales, GlaxoSmithKline pulled the only available Lyme disease vaccine, Lymerix, off the market Tuesday. The U.S Food and Drug Administration (FDA) first approved the controversial vaccine in 1998. Lyme disease is transmitted to humans through the bites of ticks infected with the bacterium Borrelia b

Lyme disease is on the rise according to a new report released by the Centers for Disease Control and Prevention (CDC). The CDC recorded 17,730 cases in 2000, up eight percent from 1999. CDC officials say the alarming number of cases may be caused by increasing development of woodland areas where ticks are commonly fo

With deer tick season peaking, the debate surrounding Lyme disease and its various treatments and vaccine is raging. The tiny deer tick carries the bacteria that cause the sometimes debilitating condition. In a study published in this month's New England Journal of Medicine, Dr. Mark Klempner of Boston University foun

The pharmaceutical company GlaxoSmithKline has received many complaints regarding its Lyme disease vaccine Lymerix. Many patients who have taken the vaccine claim that they were not made aware of possible side effects, including rare cases of arthritis. Lymerix was introduced in 1998 and is the only vaccine of its

GlaxoSmithKline, the manufacturer of LYMErix, insists that the vaccine does not cause arthritis. However, many consumers who took the vaccine tend to disagree. GlaxoSmithKline developed LYMErix to prevent the tick-borne illness Lyme disease. The Food & Drug Administration approved LYMErix in 1999. Since its introduc

Over the last decade, Lyme disease has been on the rise, particularly in Connecticut, Maryland, Massachusetts, Minnesota, New Jersey, New York, Pennsylvania, Rhode Island, and Wisconsin. These states account for 90% of all Lyme disease cases. Lyme disease was first discovered in Lyme, Connecticut in 1975. In 1998, t